TGFB1 and intestinal neoplasm: In a murine model of metastatic intestinal tumor, the combination of anti-TGF-β and anti-PD-L1 showed an impressive antitumor response compared to either monotherapy.355 Currently, new approaches for simultaneous inhibition of TGF-β and PD-L1 are under evaluation.